non-diabetic
Showing 1 - 25 of >10,000
Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular
Not yet recruiting
- SGLT2 Inhibitiors Remodeling Effect
- Chronic Heart Disease
- Sodium-glucose cotransporter 2 inhibitor
- (no location specified)
Nov 14, 2023
Diabetes Trial (Lance CLEAR dental implant)
Not yet recruiting
- Diabetes
- Lance CLEAR dental implant
- (no location specified)
Aug 4, 2023
Gastric Ultrasound in Diabetic and Non-Diabetic Pregnant Women
Recruiting
- Gastric Ultrasonography
- +4 more
- Gastric ultrasonography
-
Sariyer, Istanbul, TurkeySisli Hamidiye Etfal Training and Research Hospital
Jul 29, 2023
Lipodystrophy, Dunnigan Syndrome Trial in Saint-Pierre (Bood and urine sampling)
Recruiting
- Lipodystrophy
- Dunnigan Syndrome
- Bood and urine sampling
-
Saint-Pierre, RéunionCHU La Réunion DRCI
Oct 27, 2023
Overweight or Obesity Trial in Shijiazhuang (TG103 22.5 mg, Placebo)
Not yet recruiting
- Overweight or Obesity
- TG103 22.5 mg
- Placebo
-
Shijiazhuang, Hebei, ChinaClinical Trials Information Group
Aug 18, 2023
Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo)
Not yet recruiting
- Chronic Kidney Diseases
- Empagliflozin 10 MG
- Placebo
- (no location specified)
Oct 30, 2023
Fatty Liver Disease Trial (Empagliflozin 10 MG)
Not yet recruiting
- Fatty Liver Disease
- Empagliflozin 10 MG
- (no location specified)
Jan 19, 2023
Metabolic Associated Fatty Liver Disease Trial (dapagliflozin (Forxiga))
Not yet recruiting
- Metabolic Associated Fatty Liver Disease
- dapagliflozin (Forxiga)
- (no location specified)
Mar 13, 2023
Nephrotic Syndrome Trial (Dapagliflozin and Standard therapy (ACEI or ARB)., Standard Therapy (ACEI or ARB).)
Not yet recruiting
- Nephrotic Syndrome
- Dapagliflozin and Standard therapy (ACEI or ARB).
- Standard Therapy (ACEI or ARB).
- (no location specified)
Jul 26, 2023
Diastolic Dysfunction, Obesity Trial in Cairo (Metformin)
Not yet recruiting
- Diastolic Dysfunction
- Obesity
-
Cairo, EgyptCairo University Hospitals
Apr 26, 2023
Normoglycemia, T2DM (Type 2 Diabetes) Trial in New Delhi (Bread, Mango)
Completed
- Normoglycemia
- T2DM (Type 2 Diabetes Mellitus)
- Bread
- Mango
-
New Delhi, Delhi, IndiaFortis CDOC Hospital
Sep 20, 2023
Residual Gastric Volume Measured by Ultrasound in Diabetic
Recruiting
- Diabetes Mellitus
-
Salamanca, SpainIBSAL
Jun 22, 2022
Periodontal Disease and Diabetes Mellitus
Completed
- Periodontitis, Adult
- GCF levels of fetuin A and hsCRP evaluation
-
Fayoum, Egyptfaculty of dentistry, Fayoum university
Sep 26, 2023
Chronic Kidney Diseases Trial in Lyon (impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients)
Not yet recruiting
- Chronic Kidney Diseases
- impact of Dapagliflozin on Intestinal Microbiota on chronic renal failure patients
-
Lyon, FranceNephrology department, Hôpital Lyon Sud, Hospices Civils de Lyon
Jul 28, 2023
Corneal Endothelial Changes After Phacoemulsification Trial in Cairo (Specular biomicroscopy)
Recruiting
- Corneal Endothelial Changes After Phacoemulsification
- Specular biomicroscopy
-
Cairo, EgyptCairo University
Jun 21, 2022
Non Alcoholic Steatohepatitis Trial in Tanta (Pioglitazone 30mg, Empagliflozin 10 MG)
Not yet recruiting
- Non Alcoholic Steatohepatitis
- Pioglitazone 30mg
- Empagliflozin 10 MG
-
Tanta, Gharbiya, EgyptTanta University
Nov 2, 2022
Chronic Kidney Diseases, Bone Diseases, Metabolic Trial in Mansoura (Dapagliflozin 10mg Tab, Placebo)
Active, not recruiting
- Chronic Kidney Diseases
- Bone Diseases, Metabolic
- Dapagliflozin 10mg Tab
- Placebo
-
Mansoura, Aldakahliya, EgyptUrology and Nephrology center, Mansoura University
Feb 16, 2023
SLE, Lupus Nephritis, SGLT2 Inhibitors Trial in Mansoura (dapagliflozin, )
Active, not recruiting
- SLE
- +2 more
- dapagliflozin
- placebo
-
Mansoura, EgyptUrology and Nephrology Center
Feb 18, 2023
Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)
Active, not recruiting
- Non-Alcoholic Fatty Liver Disease
- ALT-801
- Placebo
-
Montclair, California
- +12 more
Oct 11, 2022
Dapagliflozin in the Treatment of Heart Failure
Active, not recruiting
- Heart Failure
-
Cairo, Egyptcardiology department at Ain Shams university hospitals
Feb 5, 2023
Polycystic Ovary Syndrome Trial in Shenyang (Canagliflozin combined with metformin, metformin)
Completed
- Polycystic Ovary Syndrome
- Canagliflozin combined with metformin
- metformin
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Apr 13, 2022
SGLT2 INHIBITORS, Lupus Nephritis, BMD Trial in Mansoura (Dapagliflozin tablet, )
Active, not recruiting
- SGLT2 INHIBITORS
- +2 more
- Dapagliflozin tablet
- placebo
-
Mansoura, EgyptUrology and Nephrology Center
Jan 19, 2023